Characterization of the Wiskott-Aldrich syndrome protein and its role in the disease
β Scribed by Shigeaki Nonoyama; Hans D Ochs
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- English
- Weight
- 784 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0952-7915
No coin nor oath required. For personal study only.
β¦ Synopsis
Wiskott-Aldrich syndrome is an X-linked disorder characterized by thrombocytopenia, eczema and immunodeficiency. The Wiskott-Aldrich syndrome protein and the gene that encodes it have been identified by positional cloning and the protein has been shown to contain a pleckstrin-homology domain, a GTPase-binding domain, a proline-rich region and a verprolin/cofilin homology domain. Subsequent studies suggest that the protein is involved in signal transduction and the regulation of the cytoskeleton.
π SIMILAR VOLUMES
Communicated by
A case of Wiskott-Aldrich syndrome (WAS) suspected to have a deletion mutation in the WAS protein (WASP) gene had previously been reported (Ariga et al., 1997). Genomic polymerase chain reaction (PCR) suggested that exons 3-7 of the WASP gene were included in the deletion. Present Southern blot stud
## Abstract The formation of a uropod by lymphocytes (handβmirror cells) represents a morphologic stage of immune activation and motility in lymphocytes. Immune complexes have been previously shown to induce handβmirrorβcell (HMC) formation in human lymphocytes and have been associated with increas
## Abstract ## Background The genomic integration of a lentiviral vector developed for the treatment of WiskottβAldrich syndrome (WAS) was assessed by localizing the vector insertion sites (IS) in a murine model of gene therapy for the disease. ## Methods Transduced hematopoietic progenitor cell